ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

FY’78 Construction Requests $44 Million, Budget At $12 Million

December 2, 1977

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

Alternative Medicine: Testing The Boundaries Of Science

May 15, 1998

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

Award Fees Show House NCI thinks FCRF Contractors Are Performing

August 15, 1986